Literature DB >> 26637211

The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy/decortication.

Annabel J Sharkey1, Sara Tenconi2, Apostolos Nakas3, David A Waller3.   

Abstract

OBJECTIVES: For many years, extrapleural pneumonectomy (EPP) was the operation of choice for the radical management of pleural mesothelioma in the UK. However, doubts surrounding the efficacy of EPP, and the change in demographics of the affected population, have prompted a transition in our practice towards extended pleurectomy/decortication (EPD). The aim of this study was to determine the effects an intentional transition from EPP to EPD has had on patient outcome.
METHODS: Data from 362 patients undergoing radical surgery (229 EPD, 133 EPP) during 1999-2014 were included. Demographics and outcome were compared between the two groups; EPP versus EPD.
RESULTS: The median age of patients undergoing EPD was significantly higher than those undergoing EPP [57 years (range 14-70 years) vs 65 years (range 42-81 years), P < 0.001]. There was a significantly higher proportion of patients with performance status ≥1 in the EPD group (46.3 vs 35.4%, P = 0.047). There was no difference in the median length of hospital stay between the two groups [14 days (range 1-133 days) vs 13 days (range 0-93 days), P = 0.409]. There was also no difference between the groups in terms of in-hospital mortality (EPP 5.3% and EPD 6.6%, P = 0.389), 30-day mortality [EPP 8 (6.0%) and EPD 8 (3.5%), P = 0.294] or 90-day mortality [EPP 18 (13.5%) and EPD 21 (9.2%), P = 0.220]. There was a significantly higher early reoperation rate in the EPP group (15.0 vs 6.2%, P = 0.008) but a significantly higher late reoperation rate in the EPD group (0.8 vs 5.3%, P = 0.037). There was no significant difference in overall survival or disease-free interval between the two groups (P = 0.899 and P = 0.399, respectively). However, overall survival was significantly greater in patients over the age of 65 undergoing EPD (12.5 vs 4.7 months, P = 0.001).
CONCLUSION: The transition from EPP to EPD in our standard practice has enabled us to operate on more elderly, frail patients with no significant increase in use of hospital resources, and without detriment to overall survival.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Extended pleurectomy/decortication; Extrapleural pneumonectomy; Mesothelioma; Pleural mesothelioma; Survival; Thoracic surgery

Mesh:

Year:  2015        PMID: 26637211     DOI: 10.1093/ejcts/ezv403

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  15 in total

1.  Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma.

Authors:  Dimitrios E Magouliotis; Vasiliki S Tasiopoulou; Kalliopi Athanassiadi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-10-29

Review 2.  Extended pleurectomy decortication: the current role.

Authors:  Rocco Bilancia; Marco Nardini; David A Waller
Journal:  Transl Lung Cancer Res       Date:  2018-10

3.  Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

Authors:  Andreas Rimner; Marjorie G Zauderer; Daniel R Gomez; Prasad S Adusumilli; Preeti K Parhar; Abraham J Wu; Kaitlin M Woo; Ronglai Shen; Michelle S Ginsberg; Ellen D Yorke; David C Rice; Anne S Tsao; Kenneth E Rosenzweig; Valerie W Rusch; Lee M Krug
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

4.  Influence of Pleurectomy and Decortication in Health-Related Quality of Life Among Patients with Malignant Pleural Mesothelioma.

Authors:  Wickii T Vigneswaran; Diana Y Kircheva; Adrian E Rodrigues; Sydeaka Watson; Amy Durkin Celauro; Berkley Rose; Hedy L Kindler; Aliya N Husain
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 5.  Extrapleural pneumonectomy (EPP) vs. pleurectomy decortication (P/D).

Authors:  Hasan Fevzi Batirel
Journal:  Ann Transl Med       Date:  2017-06

Review 6.  A nuanced view of extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Isabelle Opitz; Walter Weder
Journal:  Ann Transl Med       Date:  2017-06

7.  Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?

Authors:  Servet Bölükbas; Michael Eberlein
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 8.  Landmark Trials in the Surgical Management of Mesothelioma.

Authors:  Taylor Kantor; Elliot Wakeam
Journal:  Ann Surg Oncol       Date:  2021-01-31       Impact factor: 5.344

Review 9.  Surgery for malignant pleural mesothelioma: an international guidelines review.

Authors:  Sara Ricciardi; Giuseppe Cardillo; Carmelina Cristina Zirafa; Francesco Carleo; Francesco Facciolo; Gabriella Fontanini; Luciano Mutti; Franca Melfi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 10.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Authors:  David A Mahvi; Rong Liu; Mark W Grinstaff; Yolonda L Colson; Chandrajit P Raut
Journal:  CA Cancer J Clin       Date:  2018-10-17       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.